Baker Bros. Advisors LP Corbus Pharmaceuticals Holdings, Inc. Transaction History

Baker Bros. Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$4.65 - $7.95 $1.15 Million - $1.97 Million	-247,450 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$5.05 - $6.8 $2.09 Million - $2.81 Million	-413,264 Reduced 62.55%	247,450 $1.25 Million
Q4 2017 Feb 14, 2018	BUY	$6.6 - $7.78 $4.36 Million - $5.14 Million	660,714	660,714 $4.69 Million

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $691M
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.